-
Mashup Score: 14Brookfield cancer patient gets ‘a second chance on life’ with stem cells from a Canadian athlete - 2 day(s) ago
Brookfield cancer survivor Tom Mix said he has “a second chance on life,” thanks to Alex…
Source: www.newstimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
Editorial Fellowship Program | Blood | American Society of Hematology .myButton { background-color:#b7000f; border-radius:3px; border:none; display:inline-block; cursor:pointer; color:#fff!important; font-family:Arial; font-size:18px; padding:12px 24px; text-decoration:none; } .myButton:hover { background-color:#b7000f; } .myButton:active { position:relative; top:1px; } .myButton:hover { background:linear-gradient(to bottom, #b7000f 5%, #eb0014 100%); background-color:#b700f; } .myButton:active { position:relative; top:1px; } Blood Editorial Fellowship Program The Blood Editorial Fellowship Program is an opportunity…
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69PRIMARY RESULTS OF THE PHASE III STIMULUS-MDS2 STUDY OF SABATOLIMAB... by Amer M. Zeidan - 4 day(s) ago
EHA Library; Zeidan A. Jun 13 2024; 422284;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 34Transplant in AML: just follow the NPM1 guide! - 5 day(s) ago
In this issue of Blood, Othman et al have identified the level of molecular measurable residual disease (MRD) in peripheral blood after 2 cycles of intensi
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 35Join me! | Managing Anemia in Low-Risk MDS - 17 day(s) ago
Don’t miss the chance to get your questions about managing anemia with low-risk MDS answered in this roundtable webinar. Register now!
Source: clinicaloptions.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Join me! | Managing Anemia in Low-Risk MDS - 17 day(s) ago
Don’t miss the chance to get your questions about managing anemia with low-risk MDS answered in this roundtable webinar. Register now!
Source: clinicaloptions.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 363Emory tenured faculty push for no-confidence vote of university president following violent protests - 18 day(s) ago
Emory University faculty gathered on campus to express concerns about the violent arrests that took place on campus on Thursday, with tenured professors calling for the university’s president, Gregory Fenves, to step down over the decision to call in state and local police to clear out the protesters.
Source: www.cnn.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission - 24 day(s) ago
Key Points. Molecular MRD after induction chemotherapy identifies patients with NPM1 AML who benefit from allogeneic transplant in first remissionPatients
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Amer H. Momany Pfizer on LinkedIn: Fill | Adoption of Multichannel Marketing by Pharmaceutical Companies | 17 comments - 26 day(s) ago
As some of you might know, I am currently in the last mile of my MBA in International Healthcare Management. My thesis topic is “Adopting Multichannel… | 17 comments on LinkedIn
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet
What an incredible story of resilience belief in face of adversity by our patient @YaleCancer. TP53-mut #AMLsm/#MDSsm is not a death sentence & patients should be given chance of curative transplant. Cancer patient gets stem cells from lacrosse player https://t.co/MFFG6X0L5o